Piracy

https://www.huffpost.com/entry/astrazeneca-vaccine-covid-blood-clots_n_604ecc3bc5b65bed87dbe398

AstraZeneca said Sunday that a safety review found no evidence its COVID-19 vaccine caused an increased risk of blood clots after several countries suspended the use of the shots earlier this week.

The company said it had conducted a “careful review” of safety data after Denmark paused the rollout of the AstraZeneca jab on Thursday after a 60-year-old woman who received the shot developed a blood clot and died. Authorities in Norway, Iceland, the Netherlands and Ireland quickly followed suit while investigations were underway, saying that the moves were precautionary and that there was no evidence of any link.

The drug manufacturer, however, sought to quell those fears on Sunday after analyzing data from the 17 million people who have already received its vaccine.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the company said in a statement.